항응고제 역전제 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00004954
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 154
Buy Now

[연구보고서] 항응고 역전제 시장은 2019년 9억 2,255만 달러에서 2027년 22억 7,654만 달러에 달할 것으로 예상된다. 시장은 2020년부터 2027년까지 CAGR 12.6%로 성장할 것으로 추정됩니다.



계획되지 않은 수술, 항응고제 요법의 과다 복용, 통제되지 않는 상황과 같은 특정 상황에서 항응고제 효과를 역전시키기 위해 항응고제 역전제가 필요합니다. 출혈. 항응고 역전 약물은 정맥 혈전색전증, 심방 세동(AF), 기계적 판막 교체 및 항인지질 항체 증후군 및 인자 V 라이덴과 같은 기타 응고 장애와 같은 의학적 상태에 사용됩니다. 항응고 역전 약물 시장 성장의 성장은 주로 심방 세동(AFib) 및 뇌졸중의 유병률 증가와 같은 요인에 기인합니다. 그러나 항응고 역전 약물의 높은 비용은 시장 성장을 제한하고 있습니다.



항응고 역전 약물의 수익성 있는 지역 시장



시장 통찰력



심방 유병률 증가 세동(AFib)



경구용 항응고제는 광범위하게 사용되며 AFib 환자의 혈전색전증 예방에 매우 효과적입니다. 그러나 항응고제를 사용하면 AFib 환자에서 출혈이 발생할 수 있습니다. 따라서 항응고 역전 약물은 출혈을 예방하는 데 사용됩니다.



질병통제예방센터(CDC)에 따르면 2018년 미국에서 AFib는 약 175,326건의 사망 진단서에 언급되었으며 그 중 약 25,845건의 주요 사망 원인이었습니다. 또한 2030년까지 미국에서 1,210만 명이 AFib에 걸릴 것으로 예상했습니다.



또한 유럽 심장학회(ESC)에 따르면 2016년에는 65세 이상 760만 명이 EU에서는 심방 세동이 있었고 그 수는 2060년까지 89% 증가하여 1,440만 명에 이를 것으로 예상됩니다. 유사하게 Stroke Association: State of the Nation 2017에 따르면 영국에서 백만 명이 넘는 사람들이 심방으로 고통받고 있습니다. 세동.



따라서 전 세계적으로 심방 세동의 높은 유병률은 시장의 성장에 유리할 것입니다.



제품 기반 통찰력



제품을 기준으로, 항응고 역전 약물 시장은 프로트롬빈 복합 농축물, 비타민 k, 프로타민, 트라넥삼산, 이다루시주맙 및 AndeXXa로 분류됩니다. 프로트롬빈 복합 농축액 부문은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 반면 AndeXXa 세그먼트는 예측 기간 동안 시장에서 가장 높은 CAGR을 등록한 것으로 추정됩니다. 프로트롬빈 복합 농축물은 신선한 냉동 혈장에 대한 신뢰할 수 있고 빠른 대안으로 널리 사용되며 과도한 출혈을 제어합니다.



항응고 역전제 시장, 제품별 - 2019년 및 2027년



유통 채널 기반 통찰력



유통 채널을 기준으로 항응고 역전제 시장은 다음과 같이 분류됩니다. 병원 약국, 소매 약국 및 기타. 병원 약국 부문은 2019년 시장에서 가장 큰 점유율을 차지했으며 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.



전략적 통찰력



제품 출시 및 승인 기업이 글로벌 입지와 제품 포트폴리오를 확장하기 위해 일반적으로 채택하는 전략입니다. 협업은 전 세계적으로 고객 기반을 확대하기 위해 항응고제 역전제 시장 참여자들이 채택한 주요 전략 중 하나이며, 이를 통해 전 세계적으로 브랜드 이름을 유지할 수 있습니다.



항응고제 역전제 시장 - 제품별





  • 프로트롬빈 복합 농축액

  • 비타민 K

  • 프로타민

  • 트라넥삼산

  • 이다루시주맙

  • AndeXXa


항응고 역전 약물 시장 - 유통 채널별





  • 병원 약국

  • 소매 약국

  • 기타< /li>

항응고 역전제 시장 – 지역별





  • 북미


    • 미국

    • 캐나다

    • 멕시코



  • 유럽


    • 프랑스

    • 독일

    • 이탈리아

    • 영국< /li>
    • 스페인

    • 기타 유럽



  • 아시아 태평양(APAC)


    • 중국

    • 인도

    • 대한민국

    • 일본

    • 호주

    • 기타 아시아 태평양



  • 중동 및 아프리카(MEA)


    • 남아프리카

    • 사우디아라비아

    • UAE

    • 나머지 MEA

    • < /ul>
    • 중남미


      • 브라질

      • 아르헨티나

      • 나머지 중남미




    회사 프로필





    • Boehringer Ingelheim International GmbH

    • Pfizer Inc

    • Octapharma AG

    • < li>Amag Pharmaceuticals, Inc.
    • Fresenius Kabi AG

    • Alexion Pharmaceuticals, Inc.(Portola Pharmaceuticals)

    • CSL Limited

    • China Biologic Products, Inc

    • Grifols, SA

    • Shanghai RAAS Blood Products Co., Ltd.


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What anticoagulant reversal drugs?

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.

What are the driving factors for the anticoagulant reversal drugs market across the globe?

The factors that are driving growth of the market are rise in prevalence of atrial fibrillation (AFib) and increase in prevalence of stroke are the major factors driving the market growth. However, high cost of anticoagulant reversal drugs is hindering the market growth.

Who are the major players in the anticoagulant reversal drugs market?

The anticoagulant reversal drugs market majorly consists of the players such as Boehringer Ingelheim International GmbH; Pfizer Inc; Octapharma AG; Amag Pharmaceuticals, Inc; Fresenius Kabi AG; Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals); CSL Limited; China Biologic Products, Inc; Grifols, S.A, and Shanghai RAAS Blood Products Co., Ltd. amongst others.

The List of Companies - Anticoagulant Reversal Drugs Market

  1. Boehringer Ingelheim International GmbH
  2. Pfizer Inc.
  3. Octapharma AG
  4. AMAG PHARMACEUTICALS, INC.
  5. Fresenius Kabi AG
  6. Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  7. CSL Limited
  8. China Biologic Products, Inc
  9. Grifols, S.A.
  10. Shanghai RAAS Blood Products Co.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports